Insulin resistance induces medial artery calcification in fructose-fed rats

Experimental Biology and Medicine

Volumn 237, Issue 1, 2012, Pages 50-57

  Zhou, Ye Bo ^a,b   Zhang, Jing ^c   Cai, Yan ^d   Teng, Xu ^d   Duan, Xiao Hui ^d   Song, Jun Qiu ^d   Du, Jie ^a   Tang, Chao Shu ^a,d   Qi, Yong Fen ^a,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Bone related protein; Fructose; Insulin resistance; Medial artery calcification; Vascular smooth muscle cells

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CATALASE; CHOLESTEROL; DRINKING WATER; FRUCTOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MESSENGER RNA; OSTEOPONTIN; OSTEOPROTEGERIN; SODIUM PHOSPHATE COTRANSPORTER 3; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RUNX1; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CALCIFICATION; ARTICLE; BONE DEVELOPMENT; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; ELASTIC FIBER; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL;

ALKALINE PHOSPHATASE; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BONE MORPHOGENETIC PROTEINS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DIETARY CARBOHYDRATES; EXTRACELLULAR MATRIX PROTEINS; FRUCTOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; OSTEOPROTEGERIN; PHOSPHORUS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; TUNICA MEDIA; VASCULAR CALCIFICATION;

RATTUS;

EID: 84862954776     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011252     Document Type: Article

References (41)

1. Shaw LJ, Raggi P, Berman DS, Callister TQ. Coronary artery calcium as a measure of biologic age. Atherosclerosis 2006;188:112-119.
2. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010;7:528-536.
3. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:978-983.
4. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 1988;31:16-23.
5. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999;100:2168-2176.
6. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006;99:1044-1059.
7. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006;26:1423-1430.
8. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008;117:2938-2948.
9. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-1154.
10. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003;23:489-494.
11. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003;63:1003-1011.
12. Cola C, Almeida M, Li D, Romeo F, Mehta JL. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun 2004;320:424-427.
13. Engelse MA, Neele JM, Bronckers AL, Pannekoek H, de Vries CJ. Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res 2001;52:281-289.
14. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
15. Renna N, Risler N, Cruzado M, Gonzalez S, Lama C, Miatello RM. Effect of nebivolol on cardiovascular changes associated with a rat model of insulin-resistance. Cell Mol Biol 2005;51:531-537.
16. Zhou YB, Jin SJ, Cai Y, Teng X, Chen L, Tang CS, Qi YF. Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats. Exp Biol Med 2009;234:908-917.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
18. Qi YF, Bu DF, Niu da D, Shi YR, Wang SH, Pang YZ, Tang CS, Du JB. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 2002;23:1141-1147.
19. Askawa T, Matashushita S. Thiobarbituric acid test for detecting lipid peroxide. Lipids 1979;14:401-406.
20. Rydén L. What are the risk factors for progression of coronary artery calcification in patients with type 2 diabetes? Nat Clin Pract Cardiovasc Med 2008;5:370-381.
21. Ahmadi N, Tirunagaram S, Hajsadeghi F, Flores F, Saeed A, Hecht H, Naghavi M, Budoff M. Concomitant insulin resistance and impaired vascular function is associated with increased coronary artery calcification. Int J Cardiol 2010;144:163-165.
22. Heinonen SE, Leppänen P, Kholová I, Lumivuori H, Häkkinen SK, Bosch F, Laakso M, Ylä-Herttuala S. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Circ Res 2007;101:1058-1067.
23. Qiao JH, Mertens RB, Fishbein MC, Geller SA. Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: morphologic evidence of enchondral ossification. Hum Pathol 2003;34:402-407.
24. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987;10:512-516.
25. Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gammacarboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983;117:765-7761.
26. Hackeng TM, Rosing J, Spronk HM, Vermeer C. Total chemical synthesis of human matrix Gla protein. Protein Sci 2001;10:864-870.
27. Yagami K, Suh JY, Enomoto-Iwamoto M, Koyama E, Abrams WR, Shapiro IM, Pacifici M, Iwamoto M. Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 1999;147:1097-1108.
28. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003;1:178-185.
29. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 2001;276:14044-14052.
30. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268.
31. Olesen P, Nguyen K, Wogensen L, Ledet T, Rasmussen LM. Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol 2007;292:H1058-H1064.
32. Chen NX, Duan D, O'Neill KD, Moe SM. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 2006;21:3435-3442.
33. Sodhi CP, Phadke SA, Batlle D, Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 2001;50:1482-1490.
34. Mori S, Takemoto M, Yokote K, Asaumi S, Saito Y. Hyperglycaemia-induced alteration of vascular smooth muscle phenotype. J Diabetes Complications 2002;16:65-68.
35. Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 2006;84:93-101.
36. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004;95:560-567.
37. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004;15:2959-2964.
38. Liu H, Yuan L, Xu S, Zhang T, Wang K. Cholestane-3beta, 5alpha, 6beta-triol promotes vascular smooth muscle cells calcification. Life Sci 2004;76:533-543.
39. Du X, Stotcklauser-Farber K, Rosen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med 1999;27:752-763.
40. Chen B, Jiang D, Tang L. Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes. Life Sci 2006;79:1040-1048.
41. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G, Azay J. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005;179:43-49.